To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MCM5TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
239 representative clones for gene MCM5 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DC349224   .a 1 to 580 1 to 580   tiling clone,   580/580
(100 %)
0 diff
(100 %id)
DC319579 brain .a 12 to 596 1 to 585       585/585
(100 %)
0 diff
(100 %id)
DC391445 Spleen .a 39 to 608 1 to 570       570/570
(100 %)
0 diff
(100 %id)
BM787690 stomach .a 40 to 658 1 to 619       619/619
(100 %)
0 diff
(100 %id)
CR615349 Placenta Cot 25-normalized .a 43 to 2550 1 to 2508 exact     2508/2508
(100 %)
0 diff
(100 %id)
NM_006739.3   .a 43 to 2587 1 to 2545 exact RefSeq, AAA   2545/2545
(100 %)
0 diff
(100 %id)
DC415166 trachea .a 43 to 639 1 to 598       596/598
(99 %)
0 diff
(100 %id)
DC359039 lung .a 48 to 613 1 to 566       566/566
(100 %)
0 diff
(100 %id)
DC380953 placenta .a 48 to 621 1 to 574       574/574
(100 %)
0 diff
(100 %id)
DC388960 Spleen .a 48 to 613 1 to 566       566/566
(100 %)
0 diff
(100 %id)
DC410950 thymus .a 48 to 638 1 to 591       591/591
(100 %)
0 diff
(100 %id)
AK223323 thymus .a 53 to 2576 1 to 2524 S146P R681P     2524/2524
(100 %)
2 diff
(100.0 %id)
DA419488 cord Blood .a 53 to 623 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA481558   .a 53 to 623 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA014395 adrenal gland .a 54 to 629 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA078399 cerebellum .a 54 to 629 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA173964 amygdala .a 54 to 634 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DA306825 hippocampus .a 54 to 632 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA444049 tongue, tumor tissue .a 54 to 636 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DA550892   .a 54 to 879 2 to 827   capped   826/826
(100 %)
28 diff
(96.7 %id)
DA552973   .a 54 to 622 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA603259   .a 54 to 618 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA612533   .a 54 to 624 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA679035   .a 54 to 618 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA853264 placenta .a 54 to 623 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA908197   .a 54 to 620 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA911528   .a 54 to 621 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA935982 Spleen .a 54 to 645 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
DA941551 Spleen .a 54 to 645 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
DB160708 thymus .a 54 to 640 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
DA305956 hippocampus .a 55 to 647 2 to 594   capped   593/593
(100 %)
0 diff
(100 %id)
D83986   .a 55 to 2587 1 to 2525 E527V S591T A593P R594V Q595S ...     2525/2525
(100 %)
14 diff
(99.5 %id)
DA883950   .a 55 to 622 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA440105 tongue, tumor tissue .a 56 to 669 2 to 615   capped   614/614
(100 %)
0 diff
(100 %id)
DB101038 thymus .a 57 to 584 2 to 529   capped   528/528
(100 %)
0 diff
(100 %id)
DA924061 small intestine .a 59 to 627 8 to 576   capped   569/569
(100 %)
0 diff
(100 %id)
AK291136   .a 62 to 2478 1 to 2417 S423P P508A     2417/2417
(100 %)
2 diff
(100.0 %id)
BP230207 brain .a 62 to 642 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BQ440728 melanotic melanoma, skin .a 62 to 943 1 to 887       887/889
(99 %)
11 diff
(98.8 %id)
BP282327 bone marrow .a 62 to 644 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BP293932 lung .a 62 to 643 1 to 582       582/582
(100 %)
0 diff
(100 %id)
AK312533 tongue, tumor tissue .a 63 to 2341 1 to 2279 exact     2279/2279
(100 %)
3 diff
(99.9 %id)
DA031420   .a 63 to 634 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA051417   .a 63 to 650 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DA274240 corpus callosum .a 63 to 629 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA445206 tongue, tumor tissue .a 63 to 634 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA451901 tongue, tumor tissue .a 63 to 648 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DA478443   .a 63 to 631 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA504079 brain .a 63 to 639 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
BU845031 ovary, teratocarcinoma, cell line .a 63 to 889 1 to 827       827/918
(90 %)
2 diff
(99.8 %id)
BU850199 ovary, teratocarcinoma, cell line .a 63 to 890 1 to 833       833/913
(91 %)
8 diff
(99.2 %id)
DA654936   .a 63 to 631 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA744920   .a 63 to 642 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA861750 placenta .a 63 to 629 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DB106824 thymus .a 63 to 630 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DB111047 thymus .a 63 to 629 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DB120905 thymus .a 63 to 638 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA464863   .a 64 to 631 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA479367   .a 65 to 636 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA748404   .a 65 to 630 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA977244 synovial membrane tissue from rheumatioidarthritis .a 65 to 635 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DB087147 testis .a 65 to 633 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA508309 brain .a 66 to 650 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
DA968920 stomach .a 66 to 641 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA154957 amygdala .a 67 to 645 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
BQ222354 leiomyosarcoma, uterus .a 67 to 1047 1 to 990       990/991
(99 %)
33 diff
(96.7 %id)
CX164517 human embryonic stem cells differentiated toan early endodermal cell type .a 68 to 847 1 to 780       780/780
(100 %)
0 diff
(100 %id)
CX872598 embryonic stem .a 68 to 847 1 to 780       780/780
(100 %)
0 diff
(100 %id)
BM927583 lymph, lymphoma, cell line .a 70 to 888 1 to 821       821/1003
(81 %)
7 diff
(99.4 %id)
BM927634 lymph, lymphoma, cell line .a 70 to 944 1 to 882       882/1005
(87 %)
13 diff
(98.8 %id)
BQ065023 lymph, lymphoma, cell line .a 70 to 980 1 to 915       915/1001
(91 %)
8 diff
(99.3 %id)
CN304294 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 71 to 642 1 to 572       572/572
(100 %)
0 diff
(100 %id)
BX331344 Neuroblastoma Cot 10-normalized .a 71 to 981 1 to 907       907/907
(100 %)
4 diff
(99.6 %id)
BQ069268 brain, neuroblastoma, cell line .a 72 to 980 1 to 919       919/1020
(90 %)
16 diff
(98.5 %id)
BQ065931 lymph, lymphoma, cell line .a 72 to 980 1 to 912       912/1010
(90 %)
8 diff
(99.3 %id)
BQ066237 lymph, lymphoma, cell line .a 72 to 890 1 to 820       820/1003
(81 %)
3 diff
(99.8 %id)
BQ642797 lymph, lymphoma, cell line .a 72 to 978 1 to 914       914/920
(99 %)
12 diff
(98.7 %id)
BU556785 ovary, teratocarcinoma, cell line .a 72 to 889 1 to 819       819/896
(91 %)
4 diff
(99.6 %id)
BU557310 ovary, teratocarcinoma, cell line .a 72 to 944 1 to 879       879/880
(99 %)
7 diff
(99.3 %id)
BU148519 carcinoma, cell line, Prostate .a 75 to 889 1 to 818       818/865
(94 %)
5 diff
(99.5 %id)
BQ943544 carcinoma, cell line, Prostate .a 75 to 958 1 to 889       889/897
(99 %)
11 diff
(98.8 %id)
BQ957762 carcinoma, cell line, Prostate .a 75 to 967 1 to 894       894/894
(100 %)
5 diff
(99.5 %id)
BU541449 carcinoma, cell line, Prostate .a 75 to 978 1 to 913       913/917
(99 %)
10 diff
(99.0 %id)
BU165017 eye, retinoblastoma .a 76 to 968 1 to 898       898/898
(100 %)
7 diff
(99.3 %id)
DR156917 human embryonic stem cells differentiated toan early endodermal cell type .a 76 to 882 1 to 807       807/807
(100 %)
0 diff
(100 %id)
CX871261 embryonic stem .a 77 to 836 1 to 760       760/760
(100 %)
0 diff
(100 %id)
DR158737 human embryonic stem cells differentiated toan early endodermal cell type .a 77 to 700 1 to 624       624/624
(100 %)
0 diff
(100 %id)
CR591959 Neuroblastoma Cot 10-normalized .a 78 to 2529 1 to 2452 exact     2452/2452
(100 %)
0 diff
(100 %id)
BY799666 eye .a 78 to 678 1 to 601       601/601
(100 %)
0 diff
(100 %id)
BQ650287 hepatocellular carcinoma, cell line, Liver .a 79 to 890 1 to 815       815/997
(81 %)
18 diff
(98.2 %id)
BE389972 endometrium, adenocarcinoma cell line, uterus .a 81 to 711 1 to 630       630/630
(100 %)
1 diff
(99.9 %id)
BM470663 leiomyosarcoma, uterus .a 82 to 993 1 to 917       917/984
(93 %)
12 diff
(98.8 %id)
BM558890 eye, retinoblastoma .a 82 to 1065 1 to 993       993/1004
(98 %)
14 diff
(98.7 %id)
BU178502 melanotic melanoma, skin .a 83 to 973 1 to 900       898/902
(99 %)
18 diff
(98.1 %id)
BQ232104 melanotic melanoma, skin .a 84 to 943 1 to 862       862/862
(100 %)
2 diff
(99.8 %id)
BQ645833 hepatocellular carcinoma, cell line, Liver .a 85 to 976 1 to 896       896/896
(100 %)
5 diff
(99.5 %id)
BQ646119 hepatocellular carcinoma, cell line, Liver .a 85 to 889 1 to 807       807/971
(83 %)
12 diff
(98.8 %id)
BM480184 eye, retinoblastoma .a 86 to 1056 1 to 977       977/1079
(90 %)
15 diff
(98.7 %id)
AU132743   .a 86 to 890 2 to 807   capped   806/835
(96 %)
12 diff
(98.6 %id)
CR984474 T-Lymphocytes .a 87 to 842 1 to 756       756/761
(99 %)
1 diff
(99.9 %id)
CR989869 T-Lymphocytes .a 87 to 695 1 to 609       609/615
(99 %)
1 diff
(99.9 %id)
BM456525 lymph, lymphoma, cell line .a 88 to 866 1 to 781       781/1047
(74 %)
17 diff
(98.4 %id)
DA541144 lung .a 89 to 669 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
BQ440710 melanotic melanoma, skin .a 89 to 887 1 to 808       808/913
(88 %)
15 diff
(98.4 %id)
CX872671 embryonic stem .a 89 to 841 1 to 753       753/753
(100 %)
0 diff
(100 %id)
DR159283 human embryonic stem cells differentiated toan early endodermal cell type .a 89 to 900 1 to 812       812/812
(100 %)
0 diff
(100 %id)
DA644000   .a 89 to 672 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
BQ219621 leiomyosarcoma, uterus .a 90 to 1109 1 to 1025       1025/1029
(99 %)
20 diff
(98.1 %id)
BM457715 lymph, lymphoma, cell line .a 91 to 962 1 to 881       879/924
(95 %)
17 diff
(98.2 %id)
DA038712   .a 92 to 658 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA049300   .a 95 to 661 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
BU192073 embryonal carcinoma, cell line, testis .a 96 to 969 1 to 879       879/879
(100 %)
6 diff
(99.4 %id)
BQ434878 leiomyosarcoma, uterus .a 96 to 963 1 to 873       873/873
(100 %)
7 diff
(99.2 %id)
CX873547 embryonic stem .a 96 to 901 1 to 806       806/806
(100 %)
0 diff
(100 %id)
BE297582 muscle, rhabdomyosarcoma .a 97 to 711 1 to 615       615/615
(100 %)
0 diff
(100 %id)
BU538182 adenocarcinoma, cell line, breast .a 98 to 1035 1 to 943       943/943
(100 %)
8 diff
(99.2 %id)
CR611599 Neuroblastoma Cot 10-normalized .a 101 to 2569 1 to 2469 exact     2469/2469
(100 %)
0 diff
(100 %id)
BE390184 endometrium, adenocarcinoma cell line, uterus .a 101 to 732 1 to 632       632/657
(96 %)
0 diff
(100 %id)
BU179314 hepatocellular carcinoma, cell line, Liver .a 101 to 1163 1 to 1068       1068/1070
(99 %)
19 diff
(98.3 %id)
BQ645655 hepatocellular carcinoma, cell line, Liver .a 101 to 890 1 to 791       791/928
(85 %)
15 diff
(98.4 %id)
BU839453 hepatocellular carcinoma, cell line, Liver .a 101 to 890 1 to 791       791/880
(89 %)
2 diff
(99.8 %id)
BQ649375 hepatocellular carcinoma, cell line, Liver .a 101 to 980 1 to 881       881/962
(91 %)
11 diff
(98.9 %id)
BQ647973 hepatocellular carcinoma, cell line, Liver .a 101 to 1054 1 to 957       957/957
(100 %)
30 diff
(96.9 %id)
TI_154177993   .a 102 to 999 70 to 950       881/944
(93 %)
22 diff
(97.7 %id)
CR456517   .a 103 to 2372 1 to 2270 exact     2270/2270
(100 %)
0 diff
(100 %id)
BM832544 stomach .a 103 to 675 1 to 573       573/573
(100 %)
0 diff
(100 %id)
DA620893   .a 104 to 695 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
DA789579 brain .a 110 to 694 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
CX752905 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 111 to 866 1 to 749     Submitted on the opposite strand 749/767
(97 %)
17 diff
(97.8 %id)
BU166135 melanotic melanoma, skin .a 112 to 928 1 to 825       825/834
(98 %)
9 diff
(99.0 %id)
DA906951   .a 112 to 681 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BU156108 melanotic melanoma, skin .a 113 to 975 1 to 866       866/866
(100 %)
5 diff
(99.5 %id)
BQ213876 melanotic melanoma, skin .a 115 to 890 1 to 778       778/867
(89 %)
3 diff
(99.7 %id)
X74795 cervix carcinoma .a 115 to 2587 1 to 2473 exact tiling clone, AAA   2473/2473
(100 %)
0 diff
(100 %id)
CN304288 embryonic stem cells, DMSO-treated H9 cellline .a 117 to 860 9 to 752       744/752
(98 %)
5 diff
(99.4 %id)
CN304302 embryonic stem cells, cell lines H1, H7, andH9 .a 130 to 694 1 to 565       565/565
(100 %)
0 diff
(100 %id)
CU013405 Synthetic constructs .a 136 to 2338 19 to 2221       2203/2236
(98 %)
7 diff
(99.7 %id)
CU013117 Synthetic constructs .a 136 to 2341 19 to 2224 exact     2206/2239
(98 %)
7 diff
(99.7 %id)
CV023160 mixed .a 137 to 758 1 to 622       622/627
(99 %)
2 diff
(99.7 %id)
BE260388 brain, neuroblastoma .a 148 to 736 1 to 589       589/589
(100 %)
0 diff
(100 %id)
BQ059059 lymph, lymphoma, cell line .a 182 to 1172 1 to 1002       1002/1050
(95 %)
17 diff
(98.4 %id)
DA576817   .a 243 to 812 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BQ683703 melanotic melanoma, cell line, skin .a 265 to 1056 1 to 792       792/931
(85 %)
10 diff
(99.0 %id)
BU557340 ovary, teratocarcinoma, cell line .a 303 to 1097 1 to 795       795/846
(93 %)
4 diff
(99.6 %id)
CN304301 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 328 to 984 1 to 657       657/657
(100 %)
0 diff
(100 %id)
BM917136 blood, natural killer cells, cell line .a 437 to 1323 1 to 897       897/1131
(79 %)
18 diff
(98.5 %id)
AU126050   .a 454 to 1173 2 to 722   capped   721/821
(87 %)
4 diff
(99.6 %id)
DA001599   .a 490 to 1073 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
BG760478 melanotic melanoma, high MDR (cell line), skin .a 511 to 1341 1 to 831       831/835
(99 %)
9 diff
(99.0 %id)
BG761438 melanotic melanoma, high MDR (cell line), skin .a 511 to 1092 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BG770524 melanotic melanoma, high MDR (cell line), skin .a 511 to 1229 1 to 719       719/723
(99 %)
2 diff
(99.8 %id)
BG767144 melanotic melanoma, high MDR (cell line), skin .a 511 to 1341 1 to 834       834/840
(99 %)
8 diff
(99.1 %id)
BE739897 adenocarcinoma cell line, ovary .a 513 to 1340 1 to 833       833/909
(91 %)
24 diff
(97.4 %id)
DA435311 tongue, tumor tissue .a 516 to 1107 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
BQ223271 embryonal carcinoma, cell line, testis .a 571 to 1447 1 to 888       886/889
(99 %)
30 diff
(96.7 %id)
BM917819 blood, natural killer cells, cell line .a 675 to 1445 1 to 774       774/1026
(75 %)
11 diff
(99.0 %id)
BU190738 ductal carcinoma, cell line, Pancreas .a 687 to 1486 1 to 806       806/1040
(77 %)
14 diff
(98.7 %id)
BQ880654 ductal carcinoma, cell line, Pancreas .a 687 to 1549 1 to 869       869/889
(97 %)
16 diff
(98.3 %id)
CV807265 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 769 to 1515 1 to 750       750/750
(100 %)
7 diff
(99.1 %id)
BM719141 eye, fetal eye .a 780 to 1544 1 to 764       764/764
(100 %)
1 diff
(99.9 %id)
BQ670216 epidermoid carcinoma, cell line, salivary gland .a 823 to 1693 1 to 881       881/908
(97 %)
22 diff
(97.6 %id)
BQ054136 blood, natural killer cells, cell line .a 847 to 1712 1 to 870       870/1082
(80 %)
14 diff
(98.8 %id)
BE253723 eye, retinoblastoma .a 848 to 1640 1 to 790       790/792
(99 %)
12 diff
(98.5 %id)
CR612297 B cells (Ramos cell line) .a 862 to 2575 1 to 1714       1714/1714
(100 %)
0 diff
(100 %id)
CN304290 embryonic stem cells, DMSO-treated H9 cellline .a 873 to 1621 1 to 750       750/750
(100 %)
1 diff
(99.9 %id)
BM802048 eye, retinoblastoma .a 938 to 1723 1 to 791       791/967
(81 %)
23 diff
(97.7 %id)
BU163845 epidermoid carcinoma, cell line, salivary gland .a 1011 to 1822 1 to 815       815/904
(90 %)
5 diff
(99.5 %id)
BE388446 endometrium, adenocarcinoma cell line, uterus .a 1030 to 1696 1 to 664       664/664
(100 %)
7 diff
(99.0 %id)
BM802651 eye, retinoblastoma .a 1123 to 2105 1 to 981       981/1118
(87 %)
26 diff
(97.7 %id)
CR592264 T cells (Jurkat cell line) Cot10-normalized .a 1131 to 2559 1 to 1429       1429/1429
(100 %)
0 diff
(100 %id)
CX785429 human embryonic stem cells .a 1175 to 1992 1 to 818       818/818
(100 %)
0 diff
(100 %id)
BQ672003 epidermoid carcinoma, cell line, salivary gland .a 1201 to 2041 1 to 845       845/848
(99 %)
11 diff
(98.8 %id)
BU174909 epidermoid carcinoma, cell line, salivary gland .a 1201 to 1901 1 to 708       708/1026
(69 %)
8 diff
(99.3 %id)
BE314967 adenocarcinoma cell line, ovary .a 1239 to 1868 1 to 630       630/630
(100 %)
0 diff
(100 %id)
BQ669996 epidermoid carcinoma, cell line, salivary gland .a 1248 to 2057 1 to 815       815/832
(97 %)
11 diff
(98.7 %id)
BQ895922 carcinoma, cell line, Prostate .a 1298 to 2123 1 to 825       825/915
(90 %)
11 diff
(98.8 %id)
BQ935556 carcinoma, cell line, Prostate .a 1298 to 2176 1 to 882       882/926
(95 %)
25 diff
(97.4 %id)
CN304307 embryonic stem cells, cell lines H1, H7, andH9 .a 1306 to 1964 1 to 659       659/659
(100 %)
0 diff
(100 %id)
BG770644 melanotic melanoma, high MDR (cell line), skin .a 1339 to 2119 8 to 787       780/925
(84 %)
16 diff
(98.3 %id)
DA130139 alzheimer cortex .a 1475 to 2100 2 to 627   capped   626/626
(100 %)
0 diff
(100 %id)
BI869446 adenocarcinoma, cell line, Liver .a 1496 to 2279 1 to 786       786/786
(100 %)
2 diff
(99.8 %id)
TI_57228665   .a 1496 to 2279 48 to 833       786/786
(100 %)
2 diff
(99.8 %id)
BG576914 breast, mammary adenocarcinoma, cell line .a 1556 to 2460 1 to 901       901/904
(99 %)
25 diff
(97.3 %id)
BQ186483 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1677 to 2142 1 to 466   fully sequenced,   466/466
(100 %)
0 diff
(100 %id)
BG762639 melanotic melanoma, high MDR (cell line), skin .a 1715 to 2549 1 to 835       835/836
(99 %)
4 diff
(99.6 %id)
BG769149 melanotic melanoma, high MDR (cell line), skin .a 1715 to 2477 1 to 757       757/759
(99 %)
11 diff
(98.6 %id)
BG389992 embryonal carcinoma, cell line, testis .a 1728 to 2543 1 to 808       808/857
(94 %)
20 diff
(97.7 %id)
BU850061 ovary, teratocarcinoma, cell line .a 1758 to 2588 1 to 837       837/918
(91 %)
13 diff
(98.6 %id)
BQ772212 Chondrosarcoma Cell line .a 1840 to 2587 765 to 19   AAA   747/753
(99 %)
1 diff
(99.9 %id)
BX111302 heart .a 1848 to 2508 1 to 662       662/671
(98 %)
2 diff
(99.8 %id)
AU149584   .a 1857 to 2586 734 to 1       734/735
(99 %)
16 diff
(97.9 %id)
BM683099 eye, fetal eye .a 1893 to 2587 714 to 19   AAA   696/696
(100 %)
2 diff
(99.8 %id)
BU855896 ovary, teratocarcinoma, cell line .a 1930 to 2584 1 to 655   AAA   655/655
(100 %)
1 diff
(99.9 %id)
BU932111 ovary, teratocarcinoma, cell line .a 1930 to 2583 1 to 653   AAA   653/653
(100 %)
1 diff
(99.9 %id)
BQ643113 lymph, lymphoma, cell line .a 1968 to 2587 664 to 45   AAA Submitted on the opposite strand 620/869
(71 %)
0 diff
(100 %id)
CA439402 lung, Metastatic Chondrosarcoma .a 1976 to 2587 630 to 19   AAA   612/612
(100 %)
1 diff
(99.9 %id)
BM799731 eye, retinoblastoma .a 2014 to 2587 1 to 574   AAA   574/574
(100 %)
0 diff
(100 %id)
AU154216   .a 2066 to 2587 523 to 1       523/524
(99 %)
5 diff
(99.1 %id)
CK301002 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 2081 to 2587 526 to 19   fully sequenced, AAA   508/508
(100 %)
2 diff
(99.7 %id)
DB342229 thymus .a 2084 to 2587 505 to 1       505/505
(100 %)
3 diff
(99.5 %id)
CR617289 Placenta Cot 25-normalized .b 1 to 2374 1 to 2374 exact tiling clone,   2374/2374
(100 %)
0 diff
(100 %id)
AK122853 substantia nigra .b 10 to 2402 1 to 2393 E277D F588S tiling clone, available from FLJ,   2393/2393
(100 %)
4 diff
(99.9 %id)
DA349863 substantia nigra .b 11 to 605 2 to 596   capped   595/595
(100 %)
1 diff
(99.9 %id)
CR601762 Neuroblastoma Cot 25-normalized .c 1 to 2476 5 to 2480 exact tiling clone,   2480/2480
(100 %)
0 diff
(100 %id)
AW673330 cervix .c 8 to 278 1 to 271       271/271
(100 %)
6 diff
(97.8 %id)
AW675690 cervix .c 1957 to 2501 545 to 1   tiling clone,   545/545
(100 %)
0 diff
(100 %id)
DA985876 synovial membrane tissue from rheumatioidarthritis .d 1 to 562 2 to 563   tiling clone, capped   562/562
(100 %)
0 diff
(100 %id)
TI_57238041   .d 5 to 594 33 to 623       591/851
(69 %)
9 diff
(99.0 %id)
DB135869 thymus .d 12 to 560 2 to 550   capped   549/549
(100 %)
11 diff
(98.0 %id)
AB209612 Spleen .d 43 to 4641 1 to 4598 F94L A95L A97P V98* tiling clone,   4598/4598
(100 %)
1 diff
(100.0 %id)
BI772227 pooled lung and spleen .d 45 to 830 1 to 788       788/792
(99 %)
6 diff
(99.3 %id)
TI_57180287   .d 45 to 830 64 to 851       788/855
(92 %)
12 diff
(98.6 %id)
BQ709777 Spleen .d 62 to 829 16 to 786       771/919
(83 %)
13 diff
(98.6 %id)
BQ709833 Spleen .d 63 to 829 1 to 769       769/931
(82 %)
14 diff
(98.5 %id)
BQ707315 Spleen .d 63 to 821 1 to 775       773/961
(80 %)
26 diff
(97.3 %id)
BP304764   .d 75 to 649 1 to 574       574/575
(99 %)
11 diff
(98.1 %id)
BI907841 leukocyte .d 87 to 824 1 to 742       742/743
(99 %)
17 diff
(97.8 %id)
TI_57234996   .d 87 to 824 30 to 771       742/772
(96 %)
23 diff
(97.1 %id)
DA462944   .d 106 to 666 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA953734 Spleen .d 135 to 690 2 to 557   capped   556/556
(100 %)
2 diff
(99.7 %id)
DA936338 Spleen .d 139 to 706 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA959978 Spleen .d 139 to 677 2 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
CN275314 embryonic stem cells, DMSO-treated H9 cellline .d 1503 to 2169 1 to 667       667/667
(100 %)
2 diff
(99.8 %id)
CN283856 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 1803 to 2460 1 to 658       658/658
(100 %)
0 diff
(100 %id)
BP872977 embryonal kidney .d 1851 to 2433 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
CN371317 embryonic stem cells, cell lines H1, H7, andH9 .d 2331 to 2532 1 to 202       202/204
(99 %)
2 diff
(99.1 %id)
CN371318 embryonic stem cells, DMSO-treated H9 cellline .d 2372 to 2785 1 to 414       414/414
(100 %)
1 diff
(99.8 %id)
BM824441 Ascites, stomach .d 3184 to 3661 1 to 478       478/478
(100 %)
0 diff
(100 %id)
CN276746 embryonic stem cells, DMSO-treated H9 cellline .d 3456 to 3943 1 to 488       488/488
(100 %)
0 diff
(100 %id)
T84924 liver and spleen .d 3974 to 4301 1 to 334       334/339
(98 %)
9 diff
(97.4 %id)
H59968 liver and spleen .d 4041 to 4437 1 to 401   fully sequenced,   401/401
(100 %)
10 diff
(97.6 %id)
H71753 liver and spleen .d 4041 to 4338 1 to 296   fully sequenced,   296/296
(100 %)
2 diff
(99.4 %id)
W78753 liver and spleen .d 4041 to 4400 1 to 368   fully sequenced,   368/368
(100 %)
13 diff
(96.5 %id)
AI524725 B-cell, chronic lymphotic leukemia .d 4181 to 4641 481 to 21   AAA   461/461
(100 %)
5 diff
(99.0 %id)
AW594038 pooled germ cell tumors .d 4258 to 4642 386 to 2       385/386
(99 %)
0 diff
(100 %id)
H72316 liver and spleen .d 4308 to 4647 344 to 1   fully sequenced,   344/344
(100 %)
9 diff
(97.4 %id)
W80586 liver and spleen .d 4370 to 4642 283 to 1   tiling clone, fully sequenced,   283/283
(100 %)
2 diff
(99.3 %id)
H57843 liver and spleen .d 4407 to 4628 223 to 1   fully sequenced,   223/223
(100 %)
4 diff
(98.3 %id)
T91947 liver and spleen .d 4438 to 4638 201 to 2       200/201
(99 %)
0 diff
(100 %id)
BG721685 testis .e 1 to 779 1 to 777 E3G L201S T202Q N203H I204C ... tiling clone,   777/777
(100 %)
7 diff
(99.1 %id)
BE535501 cervix .f 1 to 738 1 to 731 S191L A192R V193S R194V A195P ... tiling clone,   731/779
(93 %)
14 diff
(98.3 %id)
BE736340 adenocarcinoma, Pancreas .g 1 to 711 3 to 703   tiling clone,   703/704
(99 %)
18 diff
(97.5 %id)
DA670106   .h 1 to 553 2 to 554 exact tiling clone, capped   553/553
(100 %)
0 diff
(100 %id)
BP338614 Spleen .i 1 to 468 1 to 468 S45X A49X S70X I84X A95V ... tiling clone,   468/552
(84 %)
22 diff
(96.1 %id)
DA620963   .j 1 to 586 2 to 587 exact tiling clone, capped   586/586
(100 %)
1 diff
(99.9 %id)
DC390213 Spleen .k 1 to 530 2 to 532 exact tiling clone,   532/532
(100 %)
1 diff
(99.9 %id)
CA389342 eye, RPE/choroid .k 252 to 905 1 to 654   tiling clone,   654/654
(100 %)
0 diff
(100 %id)
DC408603 thymus .l 1 to 451 1 to 452 S43F A45G T46D P47A R48Q ... tiling clone,   452/452
(100 %)
2 diff
(99.6 %id)
DC399469 testis .m 1 to 535 5 to 540 A37C S38F R39K S40E S41F ... tiling clone,   540/540
(100 %)
2 diff
(99.7 %id)
392 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI